Figure 2

Overall survival according to treatment arms. (A) Survival for all study patients; VC (n=218, censored n=12) and GC (n=214, censored=11). (B) Survival for PS 0/1 patients; VC (n=156, censored n=11) and GC (n=153, censored n=9).